Last week, a federal judge ruled that the Food and Drug Administration (FDA) cannot prohibit a pharmaceutical company from marketing its drugs for off-label uses if its claims are truthful and not ...

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Labeling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's ...

Resource Label is a national label company Founded in 1986, MedLit is based in New Jersey and North Carolina CORE invests in North American lower middle-market manufacturing, industrial technology, ...

Rhythm Pharmaceuticals (RYTM) added ~8% in the premarket on Friday after the U.S. Food and Drug Administration (FDA) approved a label expansion for its lead asset, setmelanotide, to allow its use in ...

Analyst insight: The pharmaceutical industry is making significant progress in standardizing labels and serialization across supply chains. A group of U.S. pharmaceutical and healthcare providers have ...

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Label Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering. The global pharmaceutical label ...

LEO Pharma has submitted a label expansion application to EMA to expand Anzupgo® (delgocitinib) cream to adolescent patients (12–17 years) with moderate to severe chronic hand eczema (CHE) for whom ...

Par Pharmaceutical last week asked a federal court to tell the FDA to back off and allow the company to detail docs about using its Megace ES to treat AIDS-related wasting. The appetite-stimulating ...

When nearly 20 years ago, the Food and Drug Administration (FDA) issued a new rule 1 that pharmaceutical manufacturers must include a linear bar code on all immediate drug packages that included each ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

GW Pharmaceuticals PLC- ADR GWPH shares are retreating following the release of fourth-quarter results. GW Pharmaceuticals reported quarterly losses of 7 cents per share, which beat the consensus ...